Hsp90 as an anti-cancer target

Drug Resistance Updates

Volumn 2, Issue 3, 1999, Pages 165-172

  Neckers, Len ^a   Mimnaugh, Edward ^a   Schulte, Theodor W ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANSAMYCIN DERIVATIVE; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; CASEIN KINASE II; CHAPERONE; CYCLIN DEPENDENT KINASE; GELDANAMYCIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 90; IMMUNOPHILIN; NATURAL PRODUCT; ONCOPROTEIN; PROTEIN KINASE P60; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; RADICICOL; RETINOBLASTOMA PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; DRUG TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033150335     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0082     Document Type: Article

References (97)

1. Ferrarini M., Heltai S., Zocchi M. R. Unusual expression and localization of heat-shock proteins in human tumor cells. Int J Cancer. 51:1992;613-619.
2. Hickey E., Brandon S. E., Smale G. Sequence and regulation of a gene encoding a human 89-kilodalton heat shock protein. Mol Cell Biol. 9:1989;2615-2626.
3. Perdew G. H., Hord N., Hollenback C. E. Localization and characterization of the 86- and 84-kDa heat shock proteins in Hepa 1c1c7 cells. Exp Cell Res. 209:1993;350-356.
4. Little E., Ramakrishnan M., Roy B. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit Rev Eukaryot Gene Expr. 4:1994;1-18.
5. Wearsch P. A., and Nicchitta C. V. Purification and partial molecular characterization of GRP94, an ER resident chaperone. Protein Expr Purif. 7:1996;114-121.
6. Chen C. F., Chen Y., Dai K. A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol. 16:1996;4691-4699.
7. Song H. Y., Dunbar J. D., Zhang Y. X. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J Biol Chem. 270:1995;3574-3581.
8. Minami Y., Kawasaki H., Miyata Y. Analysis of native forms and isoform compositions of the mouse 90-kDa heat shock protein, HSP90. J Biol Chem. 266:1991;10099-100103.
9. Minami Y., Kimura Y., Kawasaki H. The carboxy-terminal region of mammalian HSP90 is required for its dimerization and function in vivo. Mol Cell Biol. 14:1994;1459-1464.
10. Akner G., Mossberg K., Sundqvist K. G. Evidence for reversible, non-microtubule and non-microfilament-dependent nuclear translocation of hsp90 after heat shock in human fibroblasts. Eur J Cell Biol. 58:1992;356-364.
11. Gasc J. M., Renoir J. M., Faber L. E. Nuclear localization of two steroid receptor-associated proteins, hsp90 and p59. Exp Cell Res. 186:1990;362-367.
12. Neckers L. M., Mimnaugh E., and Schulte T. W. The Hsp90 chaperone family. Stress Proteins. 1998.
13. Smith D. F., Whitesell L., Katsanis E. Molecular chaperones: Biology and prospects for pharmacological intervention. Pharmacol Rev. 50:1998;493-513.
14. Csermely P., Schnaider T., Soti C. The 90-kDa molecular chaperone family: Structure, function, and clinical application. A comprehensive review. Pharmacol Ther. 79:1998;129-168.
15. Toft D. O. Recent advances in the study of Hsp90 structure and mechanism of action. Trends Endocrin Met. 9:1998;238-243.
16. Bohen S. P., Yamamoto K. R. Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc Natl Acad Sci USA. 90:1993;11424-11428.
17. Picard D., Khursheed B., Garabedian M. J. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature. 348:1990;166-168.
18. Xu Y., Lindquist S. Heat-shock protein hsp90 governs the activity of pp60v-src kinase. Proc Natl Acad Sci USA. 90:1993;7074-7078.
19. Whitesell L., Mimnaugh E. G., De C. B. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA. 91:1994;8324-8328.
20. Johnson J. L., Toft D. O. Binding of p23 and hsp90 during assembly with the progesterone receptor. Mol Endocrinol. 9:1995;670-678.
21. Smith D. F., Whitesell L., Nair S. C. Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol. 15:1995;6804-6812.
22. Sullivan W., Stensgard B., Caucutt G. Nucleotides and two functional states of hsp90. J Biol Chem. 272:1997;8007-8012.
23. An W. G., Schnur R. C., Neckers L. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates well with antiproliferative activity. Cancer Chemother Pharmacol. 40:1997;60-64.
24. Grenert J. P., Sullivan W. P., Fadden P. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J Biol Chem. 272:1997;23843-23850.
25. Prodromou C., Roe S. M., Piper P. W. A molecular clamp in the crystal structure of the N-terminal domain of the yeast Hsp90 chaperone. Nat Struct Biol. 4:1997;477-482.
26. Stebbins C. E., Russo A. A., Schneider C. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 89:1997;239-250.
27. Bergerat A., de M. B., Gadelle D. An atypical topoisomerase II from Archaea with implications for meiotic recombination. Nature. 386:1997;414-417.
28. Csermely P., Kajtar J., Hollosi M. ATP induces a conformational change of the 90-kDa heat shock protein (hsp90). J Biol Chem. 268:1993;1901-1907.
29. Nadeau K., Das A., and Walsh C. T. Hsp90 chaperonins possess ATPase activity and bind heat shock transcription factors and peptidyl prolyl isomerases. J Biol Chem. 268:1993;1479-14787.
30. Csermely P., Miyata Y., Schnaider T. Autophosphorylation of grp94 (endoplasmin). J Biol Chem. 270:1995;6381-6388.
31. Wearsch P. A., Nicchitta C. V. Interaction of endoplasmic reticulum chaperone GRP94 with peptide substrates is adenine nucleotide-independent. J Biol Chem. 272:1997;5152-5156.
32. Jakob U., Scheibel T., Bose S. Assessment of the ATP binding properties of Hsp90. J Biol Chem. 271:1996;10035-10041.
33. Scheibel T., Neuhofen S., Weikl T. ATP-binding properties of human Hsp90. J Biol Chem. 272:1997;18608-18613.
34. Prodromou C., Roe S. M., O'Brien R. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell. 90:1997;65-75.
35. Louvion J. F., Warth R., and Picard D. Two eukaryote-specific regions of Hsp82 are dispensable for its viability and signal transduction function in yeast. Proc Natl Acad Sci USA. 93:1996;13937-13942.
36. Johnson B. D., Schumacher R. J., Ross E. D. Hop modulates hsp70/hsp90 interactions in protein folding. J Biol Chem. 273:1998;3679-3686.
37. Panaretou B., Prodromou C., Roe S. M. ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivo. EMBO J. 17:1998;4829-4836.
38. Prodromou C., Siligardi G., O'Brien R. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J. 18:1999;754-762.
39. Schulte T. W., Akinaga S., Soga S. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell Stress and Chaperones. 3:1998;100-108.
40. Sharma S. V., Agatsuma T., Nakano H. Targeting of the protein chaperone Hsp90 by the transformation suppressing agent, radicicol. Oncogene. 16:1998;2639-2645.
41. Roe S. M., Prodromou C., O'Brien R. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J Med Chem. 42:1999;260-266.
42. Blagosklonny M. V., Toretsky J., Bohen S. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90. Proc Natl Acad Sci USA. 93:1996;8379-8383.
43. Sepehrnia B., Paz I. B., Dasgupta G. Heat shock protein 84 forms a complex with mutant p53 protein predominantly within a cytoplasmic compartment of the cell. J Biol Chem. 271:1996;15084-15090.
44. Blagosklonny M. V., Toretsky J., Neckers L. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene. 11:1995;933-939.
45. Jove R., Hanafusa H. Cell transformation by the viral src oncogene. Annu Rev Cell Biol. 3:1987;31-56.
46. v-src, with two cellular proteins. Cell. 25:1981;363-372.
47. Opperman H., Levinson W., Bishop J. M. A cellular protein that associates with the transforming protein of the Rous sarcoma virus is also a heat shock protein. Proc Natl Acad Sci USA. 78:1981;1067-1071.
48. Dai K., Kobayashi R., Beach D. Physical interaction of mammalian CDC37 with CDK4. J Biol Chem. 271:1996;22030-22034.
49. Stepanova L., Leng X., Parker S. B. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev. 10:1996;1491-1502.
50. v-srcto the plasma membrane. Proc Natl Acad Sci USA. 79:1982;7117-7121.
51. Brugge J. S., Yonemoto W., Darrow D. Interaction between the Rous sarcoma virus transforming protein and two cellular phosphoproteins: analysis of the turnover and distribution of this complex. Mol Cell Biol. 3:1983;9-19.
52. srcwith cellular proteins pp50 and pp90. Curr Top Microbiol Immunol. 123:1986;1-22.
53. v-srcmutants that induce different cell transformation parameters. J Virol. 60:1986;849-857.
54. Nathan D. F., Lindquist S. Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase. Mol Cell Biol. 15:1995;3917-3925.
55. Dey B., Caplan A. J., Boschelli F. The Ydj1 molecular chaperone facilitates formation of active p60v-src in yeast. Mol Biol Cell. 7:1996;91-100.
56. Kimura Y., Yahara I., Lindquist S. Role of the protein chaperone YDJ1 in establishing Hsp90-mediated signal transduction pathways. Science. 268:1995;1362-1365.
57. Chang H. C., Nathan D. F., Lindquist S. In vivo analysis of the Hsp90 cochaperone Stil (p60). Mol Cell Biol. 17:1997;318-325.
58. Duina A. A., Chang H. C., Marsh J. A. A cyclophilin function in Hsp90-dependent signal transduction. Science. 274:1996;1713-1715.
59. Dey B., Lightbody J. J., Boschelli F. CDC37 is required for p60v-src activity in yeast. Mol Biol Cell. 7:1996;1405-1417.
60. Kimura Y., Rutherford S. L., Miyata Y. Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev. 11:1997;1775-1785.
61. Uehara Y., Hori M., Takeuchi T. Phenotypic change from transformed to normal induced by benzoquinonoid ansamycins accompanies inactivation of p60src in rat kidney cells infected with Rous sarcoma virus. Mol Cell Biol. 6:1986;2198-2206.
62. Uehara Y., Murakami Y., Suzukake T. K. Effects of herbimycin derivatives on src oncogene function in relation to antitumor activity. J Antibiot (Tokyo). 41:1988;831-834.
63. Hutchison K. A., Stancato L. F., Jove R. The protein-protein complex between pp60v-src and hsp90 is stabilized by molybdate, vanadate, tungstate, and an endogenous cytosolic metal. J Biol Chem. 267:1992;13952-13957.
64. Hartson S. D., Matts R. L. Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry. 33:1994;8912-8920.
65. Hartson S. D., Barrett D. J., Burn P. Hsp90-mediated folding of the lymphoid cell kinase p561ck. Biochemistry. 35:1996;13451-13459.
66. Lipsich L. A., Cutt J., Brugge J. S. Association of the transforming proteins of Rous, Fujinami and Y73 avian sarcoma viruses with the same two cellular proteins. Mol Cell Biol. 2:1982;875-880.
67. Nair S. C., Toran E. J., Rimerman R. A. A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor Hsf1, and the aryl hydrocarbon receptor. Cell Stress Chaperones. 1:1996;237-250.
68. Aligue R., Akhavan N. H., Russell P. A role for Hsp90 in cell cycle control: Weel tyrosine kinase activity requires interaction with Hsp90. EMBO J. 13:1994;6099-6106.
69. Miller P., DiOrio C., Moyer M. Depletion of the erbB-2 gene product p185 by benzoquinoid ansamycins. Cancer Res. 54:1994;2724-2730.
70. Chavany C., Mimnaugh E., Miller P. p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2. J Biol Chem. 271:1996;4974-4977.
71. Sakagami M., Morrison P., Welch W. J. Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases. Cell Stress and Chaperones. 4:1999;19-28.
72. Mimnaugh E. G., Chavany C., Neckers L. Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem. 271:1996;22796-22801.
73. Sepp L. L., Ma Z., Lebwohl D. E. Herbimycin A induces the 20 S proteasome-and ubiquitin-dependent degradation of receptor tyrosine kinases. J Biol Chem. 270:1995;16580-16587.
74. Marshall C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
75. Morrison D. K., Cutler R. E. The complexity of Raf-1 regulation. Curr Opin Cell Biol. 9:1997;174-179.
76. Stancato L. F., Chow Y. H., Hutchison K. A. Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system. J Biol Chem. 268:1993;21711-21716.
77. Wartmann, M. Davis, R. J. The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex, J biol chem 1994; 269: 6695-6701.
78. Stancato, L. F. Hutchison, K. A. Chakraborti, P. K. Differential effects of the reversible thiol-reactive agents arsenite and methyl methanethiosulfonate on steroid binding by the glucocorticoid receptor, Biochemistry 1993; 32: 3729-3736.
79. Stancato L. F., Chow Y. H., Owens G. J. The native v-Raf.hsp90.p50 heterocomplex contains a novel immunophilin of the FK506 binding class. J Biol Chem. 269:1994;22157-22161.
80. Schulte T. W., Blagosklonny M. V., Ingui C. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association. J Biol Chem. 270:1995;24585-24588.
81. Schulte T. W., An W. G., Neckers L. M. Geldanamycin-induced destabilization of Raf-1 involves the proteasome. Biochem Biophys Res Commun. 239:1997;655-659.
82. Whitesell L., Cook P. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol Endocrinol. 10:1996;705-712.
83. Schulte T. W., Blagosklonny M. V., Romanova L. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol Cell Biol. 16:1996;5839-5845.
84. Stancato L. F., Silverstein A. M., Owens G. J. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J Biol Chem. 272:1997;4013-4020.
85. van der Straten A., Rommel C., Dickson B. The heat shock protein 83 (Hsp83) is required for Raf-mediated signalling in Drosophila. EMBO J. 16:1997;1961-1969.
86. Miyata Y., Yahara I. The 90-kDa heat shock protein, HSP90, binds and protects casein kinase II from self-aggregation and enhances its kinase activity. J Biol Chem. 267:1992;7042-7047.
87. Shi Y., Brown E. D., Walsh C. T. Expression of recombinant human casein kinase II and recombinant heat shock protein 90 in Escherichia coli and characterization of their interactions. Proc Natl Acad Sci USA. 91:1994;2767-2771.
88. Sherr C. J. Cycling on cue. Cell. 75:1994;551-555.
89. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
90. Lamphere L., Fiore F., Xu X. Interaction between Cdc37 and Cdk4 in human cells. Oncogene. 14:1997;1999-2004.
91. Akagi T., Ono H., Shimotohno K. Tyrosine Kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells. Oncogene. 13:1996;399-405.
92. Taussig R., Gilman A. G. Mammalian membrane-bound adenylyl cyclases. J Biol Chem. 270:1995;1-4.
93. Inanobe A., Takahashi K., Katada T. Association of the beta gamma subunits of trimeric GTP-binding proteins with 90-kDa heat shock protein, hsp90. J Biochem (Tokyo). 115:1994;486-492.
94. Schmidt C. J., Neer E. J. In vitro synthesis of G protein βγ dimers. J Biol Chem. 266:1991;4538-4544.
95. Higgins J. B., Casey P. J. In vitro processing of recombinant G protein γ subunits. Requiriments for assembly of an active βγ complex. J Biol Chem. 269:1994;9067-9073.
96. Mende U., Schmidt C. J., Yi F. The G protein γ subunit. Requirements for dimerization with β subunits. J Biol Chem. 270:1995;15892-15898.
97. Nguyen D., Chen A., Mixon A. Sequence-dependent enhancement of taxol sensitivity in non-small cell lung cancer by erbB-2 tyrosine kinase inhibitor NSC330507. Proc Am Assoc Cancer Res. 40:1999;485.